论文部分内容阅读
本文应用TAD（reducedglutathione，还原型谷胱甘肽）治疗新生儿G-6-PD缺陷病17例，并与常规治疗组10例作对照，结果表明：TAD组经以胆红素测定指数均值在96小时内以20～30％的比值下降，与常规组相比，其相对比值经统计学处理在96小时内有显著差异（P＜0．05），说明TAD治疗G－6－PD缺陷病有明显疗效。
In this paper, 17 cases of neonatal G-6-PD deficiency were treated with reduced glutathione (TGA), and compared with 10 cases of conventional treatment group. The results showed that the mean of bilirubin in TAD group was (P <0.05), indicating that the TAD treatment of G-6-PD deficient disease Significant effect.